Vaginal Microbiota in Short Cervix Pregnancy: Secondary Analysis of Pessary vs. Progesterone Trial

Antonio G Amorim Filho1, Roberta C R Martins2, Lucas A M Franco2

  • 1Disciplina de Obstetricia, Departamento de Obstetricia e Ginecologia, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo 05403-000, Brazil.

PubMed

Insights

Vaginal progesterone and Arabin pessary interventions did not alter the vaginal microbiome in women at high risk for preterm birth (PTB). Both treatments demonstrated microbiological safety for PTB prevention strategies.

Area of Science:

  • Reproductive Medicine
  • Microbiome Research
  • Obstetrics

Background:

  • Preterm birth (PTB) is a major cause of neonatal mortality, especially in women with short cervixes.
  • Vaginal dysbiosis is linked to increased PTB risk.
  • The impact of progesterone (PR) and Arabin pessary (PE) on the vaginal microbiome for PTB prevention is not well understood.

Purpose of the Study:

  • To compare the effects of vaginal progesterone and Arabin pessary on vaginal microbiome composition in women at high risk for PTB.
  • To assess the microbiological safety of these interventions.

Main Methods:

  • Secondary analysis of a randomized trial involving 203 pregnant women with cervical length ≤ 25 mm.
  • 44 participants were assigned to daily vaginal progesterone (200 mg) or an Arabin pessary.
  • Vaginal swabs analyzed using 16S rRNA gene sequencing at baseline and 4 weeks post-treatment.

Main Results:

  • Most participants (80/88) exhibited a low-diversity, Lactobacillus-dominated microbiota (CST-III or CST-I/II/V).
  • No significant changes in community state types (CST), Shannon alpha diversity, or Bray-Curtis dissimilarity were observed in either the progesterone or pessary group after treatment.
  • Both interventions maintained the stability of the vaginal microbiome.

Conclusions:

  • Arabin pessary and vaginal progesterone treatments maintain vaginal microbiome stability in high-risk PTB populations.
  • These findings support the microbiological safety of both interventions for PTB prevention.
Abstract